文献速递围术期管理与 ERAS

梗阻性肥厚型心肌病外科治疗421例五年单中心经验

[Surgical treatment for obstructive hypertrophic cardiomyopathy: a five-year single-center experience of 421 cases].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2023-01-01

回顾性分析复旦大学附属中山医院心脏外科2017年1月至2021年12月421例梗阻性肥厚型心肌病手术患者的围手术期及随访资料;338例单纯室间隔心肌切除术,59例同期二尖瓣手术;院内死亡4例,随访率92.1%,术后室间隔厚度及左心室流出道压差峰值均显著降低,心功能改善。

要点

  • 多学科团队(含心脏超声医师)参与术前规划与术中监测有助于手术成功。
  • 合理二尖瓣处理策略及识别二尖瓣瓣下异常结构是手术重要环节。
  • 长柄微创手术器械的应用有助于室间隔心肌切除术取得满意早中期结果。

核心结论

  • 手术团队建设(尤其心脏超声医师参与)、合理二尖瓣处理策略、二尖瓣瓣下异常结构识别处理及长柄微创器械选用有助于室间隔心肌切除术取得满意的早中期结果。

研究设计与样本

  • 回顾性收集2017年1月至2021年12月复旦大学附属中山医院心脏外科421例梗阻性肥厚型心肌病手术患者的围手术期资料和术后随访结果。
  • 男性207例,女性214例,年龄(56.5±11.7)岁(范围:19~78岁)。
  • 术前NYHA分级Ⅱ级45例、Ⅲ级328例、Ⅳ级48例;58例为隐匿梗阻性HCM,占13.8%(58/421)。
  • 338例接受单纯室间隔心肌切除术,59例同期接受二尖瓣手术;355例经主动脉切口入路,51例经右心房-房间隔/房间沟入路。

主要发现

  • 单纯室间隔心肌切除术的主动脉阻断时间为(34.3±8.5)min(范围:21~94 min)。
  • 18例术中发生不良事件并即刻再次手术,包括残余梗阻10例、左心室游离壁破裂4例、室间隔穿孔3例、主动脉瓣穿孔1例。
  • 院内死亡4例,术后发生完全性房室传导阻滞11例。
  • 随访率92.1%(384/421),中位随访时间9个月,患者均存活;心功能Ⅰ级216例、Ⅱ级168例,较术前改善(χ2=662.73,P<0.01)。
  • 术后6个月室间隔厚度(13.6±2.5)mm比(18.2±3.0)mm(t=23.51,P<0.01),左心室流出道压差峰值(12.0±6.3)mmHg比(93.4±19.8)mmHg(1 mmHg=0.133 kPa,t=78.29,P<0.01),均较术前降低。

临床怎么用

  • 建议由多学科团队(含心脏超声医师)共同完成术前规划和术中监测,确定合理的二尖瓣处理策略。
  • 术中应识别并处理二尖瓣瓣下异常结构,可选用长柄微创手术器械辅助操作。
  • 围手术期需关注残余梗阻、左心室游离壁破裂、室间隔穿孔、主动脉瓣穿孔及完全性房室传导阻滞等不良事件。

局限性

  • 本研究为单中心回顾性分析,随访率92.1%,中位随访时间9个月,缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: To examine the short-term and mid-term effects of surgical treatment of obstructive hypertrophic cardiomyopathy (HCM) in one center. Methods: The perioperative data and short-term follow-up outcomes of 421 patients with obstructive HCM who received surgical treatment at Department of Cardiac Surgery, Zhongshan Hospital, Fudan University from January 2017 to December 2021 were analyzed retrospectively. There were 207 males and 214 females, aged (56.5±11.7) years (range: 19 to 78 years). Preoperative New York Heart Association (NYHA) classification included 45 cases of class Ⅱ, 328 cases in class Ⅲ, and 48 cases in class Ⅳ. Fifty-eight patients were diagnosed with latent obstructive HCM and 257 patients had moderate or more mitral regurgitation with 56 patients suffering from intrinsic mitral valve diseases. All procedures were completed by a multidisciplinary team, including professional echocardiologists involving in preoperative planning for proper mitral valve management strategies and intraoperative monitoring. A total of 338 patients underwent septal myectomy alone, and 59 patients underwent mitral valve surgery along with myectomy. A single transaortic approach was used in 355 patients, and a right atrial-atrial septal/atrial sulcus approach was used in 51 other patients. Long-handled minimally invasive surgical instruments were used for the procedures. Student t test, Wilcoxon rank sum test, χ2 test or Fisher exact test were used to compare the data before and after surgery. Results: The aortic cross-clamping time of septal myectomy alone was (34.3±8.5) minutes (range: 21 to 94 minutes). Eighteen patients had intraoperative adverse events and underwent immediate reoperation, including residual obstruction (10 patients), left ventricular free wall rupture (4 patients), ventricular septal perforation (3 patients), and aortic valve perforation (1 patient). Four patients died during hospitalization, and 11 patients developed complete atrioventricular block requiring permanent pacemaker implantation. After discharge, 384 (92.1%) patients received a follow-up visit with a median duration of 9 months. All follow-up patients survived with significantly improved NYHA classifications: 216 patients in class Ⅰ and 168 patients in class Ⅱ (χ2=662.73, P<0.01 as compared to baseline). At 6 months after surgery, follow-up echocardiography showed that the thickness of the ventricular septum ((13.6±2.5) mm vs. (18.2±3.0) mm, t=23.51, P<0.01) and the peak left ventricular outflow tract gradient ((12.0±6.3) mmHg vs. (93.4±19.8) mmHg, 1 mmHg=0.133 kPa, t=78.29, P<0.01) were both significantly lower than baseline values. Conclusion: The construction of the surgical team (including echocardiography experts), proper mitral valve management strategies, identification and management of sub-mitral-valve abnormalities, and application of long-handled minimally invasive surgical instruments are important for the successful implementation of septal myectomy with satisfactory short-and medium-term outcomes. 目的: 探讨外科治疗梗阻性肥厚型心肌病(HCM)的早中期效果并总结经验。 方法: 回顾性收集2017年1月至2021年12月在复旦大学附属中山医院心脏外科接受手术治疗的421例梗阻性HCM患者的围手术期资料和术后随访结果。男性207例,女性214例,年龄(56.5±11.7)岁(范围:19~78岁)。术前心功能纽约心脏病学会分级Ⅱ级45例,Ⅲ级328例,Ⅳ级48例。58例为隐匿梗阻性HCM,占13.8%(58/421)。257例合并中度及以上二尖瓣反流,56例存在二尖瓣器质性病变。手术由多学科团队共同完成,心脏超声医师参与术前规划和术中监测,确定合理的二尖瓣处理策略。338例患者接受单纯室间隔心肌切除术,59例同期接受二尖瓣手术。355例为单一经主动脉切口入路,51例经右心房-房间隔/房间沟入路。术中选用长柄微创手术器械,识别并处理二尖瓣瓣下异常结构。手术前后数据的比较采用配对t检验、配对秩和检验、χ2检验或Fisher确切概率法。 结果: 单纯室间隔心肌切除术的主动脉阻断时间为(34.3±8.5)min(范围:21~94 min)。18例患者术中发生不良事件并即刻再次手术,包括残余梗阻10例、左心室游离壁破裂4例、室间隔穿孔3例、主动脉瓣穿孔1例。院内死亡4例,术后发生完全性房室传导阻滞11例。随访率为92.1%(384/421),中位随访时间9个月,患者均存活。心功能分级Ⅰ级216例,Ⅱ级168例,较术前有所改善(χ2=662.73,P<0.01)。术后6个月随访超声心动图,室间隔厚度[(13.6±2.5)mm比(18.2±3.0)mm,t=23.51,P<0.01]和左心室流出道压差峰值[(12.0±6.3)mmHg比(93.4±19.8)mmHg,1 mmHg=0.133 kPa,t=78.29,P<0.01]均较术前降低。 结论: 手术团队(尤其是心脏超声医师)的建设、合理的二尖瓣处理策略、二尖瓣瓣下异常结构的识别和处理、长柄微创手术器械的选用有助于室间隔心肌切除术取得满意的早中期结果。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu FY, Ji Q, Wang YL, et al. [Surgical treatment for obstructive hypertrophic cardiomyopathy: a five-year single-center experience of 421 cases]. Zhonghua Wai Ke Za Zhi. 2023. PMID: 36650965. doi:10.3760/cma.j.cn112139-20221129-00505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。